van Paridon, Pauline; Panova-Noeva, Marina; van Oerle, Rene et al.
Lipid-Mediated Relation between Tissue Factor Pathway Inhibitor Activity and Cardiovascular Risk Factors and Diseases in a Large Population SampleBLOOD. Bd. 132. 2018
Ghadri, Jelena R.; Kato, Ken; Cammann, Victoria L. et al.
Long-Term Prognosis of Patients With Takotsubo SyndromeJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. Bd. 72. H. 8. 2018 S. 874-882
Goebel, Sebastian; Prochaska, Juergen H.; Eggebrecht, Lisa et al.
Management of Oral Anti-Coagulation in Patients with Heart Failure-Insights from the ThrombEVAL StudyTHROMBOSIS AND HAEMOSTASIS. Bd. 118. H. 11. 2018 S. 1930-1939
Geyer, Martin; Sagoschen, Ingo; Muenzel, Thomas et al.
Multiple systemic embolic events in a patient undergoing primary percutaneous coronary intervention: drop foot and syncope as an unusual presentation of subacute ST-elevation myocardial infarctionCORONARY ARTERY DISEASE. Bd. 29. H. 3. 2018 S. 276-277
Tzikas, S.; Bakogiannis, C.; Doundoulakis, I. et al.
Neopterin for risk stratification of patients with acute chest painEUROPEAN HEART JOURNAL. Bd. 39. 2018 S. 1367-1367
Haase, Tina; Mueller, Christian; Krause, Julia et al.
Novel DNA Methylation Sites Influence GPR15 Expression in Relation to SmokingBIOMOLECULES. Bd. 8. H. 3. 2018
Keller, K.; Hobohm, L.; Munzel, T. et al.
Obesity survival paradox in patients with acute pulmonary embolismEUROPEAN HEART JOURNAL. Bd. 39. 2018 S. 497-497
Troebs, M.; Achenbach, S.; Nef, H. et al.
Outcome of percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in patients with STEMI as compared to stable CAD 2 year results from the German-Austrian ABSORBEUROPEAN HEART JOURNAL. Bd. 39. 2018 S. 137-137
Gramlich, Yves; Daiber, Andreas; Buschmann, Katja et al.
Oxidative Stress in Cardiac Tissue of Patients Undergoing Coronary Artery Bypass Graft Surgery: The Effects of Overweight and ObesityOXIDATIVE MEDICINE AND CELLULAR LONGEVITY. 2018
Kroeger, Knut; Espinola-Klein, Christine; Hoffmann, Ulrich et al.
Peripheral Arterial Disease: When is a PCSK9 Inhibitor Useful?DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. Bd. 143. H. 19. 2018 S. 1391-1396